FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take

The FDA has just made brexanolone (Zulresso) the first medicine approved specifically for post-partum depression, a potentially devastating disorder that afflicts roughly one every seven new mothers in the U.S., according to the American Psychological Association